GlassScriptPhysician profile
Mark Tan Cabahug
NPI 1922455898
$2,410.70
in general payments reported to CMS, 2019-2025
17 companies · $586 in 2025
The $586 reported for 2025 was more than what 75% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.85 · 2022: $422 · 2023: $607 · 2024: $739 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,932.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $516.27 | 2022-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $449.84 | 2022-2025 | Farxiga, Lokelma, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $426.06 | 2022-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $280.42 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Novartis Pharmaceuticals Corporation | $116.82 | 2021-2025 | |
| Abiomed | $103.93 | 2025 | |
| Pfizer INC. | $102.36 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $85.70 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $74.87 | 2022-2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.16 | 2022-2025 | Jardiance |
| Cvrx, INC. | $51.50 | 2024 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $30.94 | 2023 | Optimizer |
| Novo Nordisk INC | $25.18 | 2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $24.35 | 2022 | |
| Merck Sharp & Dohme LLC | $24.16 | 2023 | Verquvo, Belsomra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $20.24 | 2024 | Assure Wcd |
| Esperion Therapeutics, INC. | $14.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Cabahug listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.